Intermediates
VIRUPAKSHA ORGANICS LTD
B1 & B2, IDA, GANDHINAGAR, HYDERABAD – 500037 TELANGANA STATE.
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Linagliptin Intermediates | 2‐(Chloromethyl)‐4‐methylquinazoline | 109113‐72‐6 |
| 8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione | 93703-24-3 | ||
| 8‐Bromo‐7‐(but‐2‐yn‐1‐yl)‐3‐methyl‐3,7‐dihydro‐1H‐purine‐2,6‐dione | 666816‐98‐4 | ||
| (R)‐3‐(Boc‐Amino)piperidine | 309956‐78‐3 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Lurasidone Intermediates | (1R,2R)‐1,2‐Cyclohexanedimethanol | 65376‐05‐8 |
| ((1R,2R)-2-{[Methyl Sulphonyl]methyl}Cyclohexyl)Methyl methane sulfoate | 66347-68-0 | ||
| (3aR,4S,7R,7aS) 4,7‐Methano‐1H‐isoindole‐1,3(2H)‐dione | 14805‐29‐9 | ||
| (R,R)‐1,2‐Bis(methanesulfonyloxymethyl)cyclohexane | 186204‐35‐3 | ||
| 2 | Vilazodone Intermediates | 3‐(4‐Chlorobutyl)‐1H‐indole‐5‐carbonitrile | 143612‐79‐7 |
| 5‐Aminobenzofuran‐2‐carboxylic acid ethyl ester | 174775‐48‐5 | ||
| Ethyl5‐(4‐tert‐butoxy‐carbonyl‐1‐piperizinyl)benzofuran‐2‐carboxilate | 183288‐43‐9 | ||
| 3 | Escitalopram Oxalate Intermediate | 4-[4-Dimethylamino)-1-(4-Fluorophenyl)-1-Hydroxybutyl]-3-(Hydroxymethyl)Benzonitrile | 103146-25-4 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Albaconazole Intermediates | 7‐chloro‐1H‐quinazolin‐4‐one | 31374‐18‐2 |
| 2 | Efinaconazole Intermediates | 1‐[[(2R,3S)‐2‐(2,4‐Difluorophenyl)‐3‐methyloxiranyl]methyl]‐1H‐1,2,4‐triazole | 127000‐90‐2 |
| 4‐methylene piperidine‐HCl | 144230‐50‐2 | ||
| 3 | Isavuconazole Intermediates | 1‐(((2R,3S)‐2‐(2,5‐difluorophenyl)‐3‐Methyloxiran‐2‐yl)Methyl)‐1H‐1,2,4‐triazole | 241479‐73‐2 |
| (2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | 241479-74-3 | ||
| (2R,3R)‐3‐(2,5‐Difluorophenyl)‐3‐hydroxy‐2‐Methyl‐4‐(1H‐1,2,4‐triazol‐1‐yl)thiobutyramide Hydrate Hydrosulfate | 368421‐58‐3 | ||
| 4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile | 241479-67-4 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Bilastine Intermediates | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzol[d]imidazole | 110963-63-8 |
| 2-[4-(2-{4-[1(2-ethoxyethyl)-1H-1,3-benzodiazol-2-yl]piperidine-1-yl}ethyl)phenyl]-2-methylpropanoic acid | 202189-78-4 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Siponimod Intermediates | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone | 1378888-43-7 |
| 3-Azetidinecarboxylic acid | 36476-78-5 |
| CATEGORY | S.NO | INTERMEDIATE NAME | CHEMICAL NAME | CAS NO. |
|---|---|---|---|---|
| Anti Hypercholesteromia | 1 | Bempedoic acid Intermediates | ethyl 7-bromo-2,2-dimethylheptanoate | 123469-92-1 |
| Analgesic | 1 | Tapentadol HCl Intermediates | (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan-1-amine | 175591-22-7 |
| Neuropathic Heredofamilial Amyloidosis | 1 | Tafamidis Meglumine Intermediates | methyl 4-(3,5-dichlorobenzamido)-3-hydroxybenzoate | 1184581-58-5 |
| 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid | 594839-88-0 |
NOTE : The above intermediates are intended to be supplied solely for uses reasonably relating to the testing and development of information, for regulatory submmission, strictly accordingly to the section 107A of the Indian patent Act, 1970
| CATEGORY | S.NO | API / INTERMEDIATE | CHEMICAL NAME | CAS NO. |
|---|---|---|---|---|
| ANTI NEOPLASTIC AGENT | 1 | METHOTREXATE | 2,4-Diamino-6-(hydroxymethyl)pteridine hydrochloride | 73978-41-3 |
| Non-Ergot Dopamine Agonist | 1 | PRAMIPEXOLE | (R,S)-2,6 diamino-4,5,6,7-tetrahydrobenzothiazole | 104617-49-4 |
| ANTI EPILEPTIC | 1 | PERAMPANEL | 2-(2-cyanophenyl)acetic acid | 18698-99-2 |
| pyridin-2-yl acetic acid hydrochloride | 16179-97-8 |